These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9796552)

  • 1. Community-acquired antimicrobial resistance: is it controllable?
    Liñares J
    Int J Clin Pract Suppl; 1998 Jun; 95():23-6. PubMed ID: 9796552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance.
    Huovinen P; Seppălä H; Kataja J; Klaukka T
    Ciba Found Symp; 1997; 207():36-41; discussion 41-6. PubMed ID: 9189633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections and bacterial resistance in the community].
    Goettsch WG; Goossens H; de Neeling AJ; Sprenger MJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1296-9. PubMed ID: 10416482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
    Doern GV
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance.
    Martin M; Quilici S; File T; Garau J; Kureishi A; Kubin M
    J Antimicrob Chemother; 2007 May; 59(5):977-89. PubMed ID: 17395688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational approach to limiting emergence of antimicrobial drug resistance.
    Mbori-Ngacha DA
    East Afr Med J; 1997 Mar; 74(3):187-9. PubMed ID: 9185420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic kinetic and dynamic attributes for community-acquired respiratory tract infections.
    Nicolau DP
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1202-10. PubMed ID: 11187444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
    Payerl-Pal M
    Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done?
    Enne VI
    J Antimicrob Chemother; 2010 Feb; 65(2):179-82. PubMed ID: 20008449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Pfaller MA; Jones RN
    Postgrad Med; 2001 Feb; 109(2 Suppl):10-21. PubMed ID: 19667553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic resistance--bacteria fight back].
    Tambić Andrasević A
    Acta Med Croatica; 2004; 58(4):245-50. PubMed ID: 15700679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
    Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
    Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
    Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
    Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.